{"archive_url":"http://www.ebi.ac.uk/ena/next_data/view/ERX297406","experiment":{"EXPERIMENT_TYPE":"Histone H3K4me3","EXPERIMENT_ID":"ERX297406","attributes":{"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["3x 10 min; 30 sec ON/ 30 sec OFF"],"CHIP_ANTIBODY":["H3K4me3"],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_ANTIBODY_CATALOG":["pAb-003-050"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 µl"],"EXPERIMENT_TYPE":["Histone H3K4me3"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 µg"],"CHIP_ANTIBODY_LOT":["A5051-001P"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["5x 100.000 cells = 5x 6,7 µl"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked 10 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Transcription factor protocol: 100.000 cells per ChIP (5x) and pool at the end. Overnight incubation of chromatin with antibody and A/G magnetic beads. Wash twice with buffer 1, once with buffer 2 and 3 and twice with buffer 4 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Plus (UCD-300)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"ENA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/next_data/homo_sapiens/Cell_Line/U-266/Multiple_myeloma/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigWig","SIZE":"591M","NAME":"BP_U-266_c01.H3K4me3.wiggler.20130819.bw","FILE_TYPE":"CS_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/next_data/homo_sapiens/Cell_Line/U-266/Multiple_myeloma/ChIP-Seq/NCMLS/BP_U-266_c01.H3K4me3.wiggler.20130819.bw","PROTOCOL_DOC":"chip_seq","MD5":"3b5b303a4dbef0eaab19442b878ca6af"},{"FORMAT":"bigBed","SIZE":"1.4M","NAME":"BP_U-266_c01.H3K4me3.ppqt_macs2_v2.20130819.bb","FILE_TYPE":"CS_MACS_TRACK_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/next_data/homo_sapiens/Cell_Line/U-266/Multiple_myeloma/ChIP-Seq/NCMLS/BP_U-266_c01.H3K4me3.ppqt_macs2_v2.20130819.bb","PROTOCOL_DOC":"chip_seq","MD5":"14ff3373dd2652fc2ebabb915b653a29"},{"FORMAT":"BED","SIZE":"1.6M","NAME":"BP_U-266_c01.H3K4me3.ppqt_macs2_v2.20130819.bed.gz","FILE_TYPE":"CS_MACS2","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/next_data/homo_sapiens/Cell_Line/U-266/Multiple_myeloma/ChIP-Seq/NCMLS/BP_U-266_c01.H3K4me3.ppqt_macs2_v2.20130819.bed.gz","PROTOCOL_DOC":"chip_seq","MD5":"ca45bd84027f10e6349f7622f6501f44"},{"FORMAT":"Text","SIZE":"1.8M","NAME":"BP_U-266_c01.H3K4me3.ppqt_macs2_v2.20130819.xls.gz","FILE_TYPE":"CS_MACS2","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/next_data/homo_sapiens/Cell_Line/U-266/Multiple_myeloma/ChIP-Seq/NCMLS/BP_U-266_c01.H3K4me3.ppqt_macs2_v2.20130819.xls.gz","PROTOCOL_DOC":"chip_seq","MD5":"3ce4cfc924814776ce239787a159c28c"}],"sample":{"SAMPLE_DESC_2":"U-266","SAMPLE_DESC_1":"Cell Line","sample_name":"U-266_c01","SAMPLE_DESC_3":"Multiple myeloma","attributes":{"DIFFERENTIATION_METHOD":["Drexler HG chapter 16 Establishment and culture of leukemia-lymphoma cell in Cancer Cell Culture Methods and Protocols 2nd Edition Springer Berlin pp 181 to 200 in 2011"],"MOLECULE":["genomic DNA"],"DISEASE":["Multiple myeloma"],"BIOMATERIAL_PROVIDER":["DSMZ"],"BATCH":["NA"],"LINEAGE":["NA"],"BIOMATERIAL_TYPE":["Cell Line"],"DISEASE_ONTOLOGY_URI":[{"url":"http://ncimeta.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI%20MetaThesaurus&code=C0026764","label":"C0026764"}],"SAMPLE_ONTOLOGY_URI":[{"url":"http://purl.obolibrary.org/obo/CLO_0009457","label":"CLO_0009457"}],"PASSAGE":["NA"],"SEX":["Male"],"DIFFERENTIATION_STAGE":["Plasma cell"],"MEDIUM":["RPMI 1640 + 20%FBS + 1% Glutamine"],"LINE":["U-266"]},"SAMPLE_ID":"ERS333898"}}